Company profile: BioBridges
1.1 - Company Overview
Company description
- Provider of flexible expertise, services, and technologies for life sciences companies from discovery through commercialization, offering clinical operations, data management, regulatory affairs, safety & pharmacovigilance, biostatistics, and medical affairs to support studies, compliance, safety, and post-approval lifecycle.
Products and services
- Regulatory Affairs: Ensures compliance with relevant regulations and laws, liaises with regulatory agencies, and architects regulatory submissions, delivering regulatory-compliant guidance across discovery-to-commercialization pathways for pharmaceutical and device products
- Clinical Operations: Oversees and manages clinical studies, including vendor, clinical site, and CRO oversight, delivering clinical-stage coordination across discovery through commercialization initiatives
- Safety & Pharmacovigilance: Collects, detects, assesses, monitors, and prevents adverse effects associated with pharmaceutical or device products, delivering pharmacovigilance-led risk surveillance across clinical studies and commercialization stages
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioBridges
Aiolos Bio
HQ: United States
Website
- Description: Provider of therapies for respiratory and immune conditions, initially advancing AIO-001, a monoclonal antibody for moderate-to-severe asthma dosed every 6 months. Offers vaccines for meningitis, shingles, RSV, flu, and polio; specialty and general medicines for HIV, asthma, COPD, lupus, cancer, and skin diseases; conducts infectious disease research and develops respiratory/immunology solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aiolos Bio company profile →
Southwood Research
HQ: United Kingdom
Website
- Description: Provider of pre-approval regulatory science services to the pharmaceutical and biotech industries, focusing on the science behind each product and delivering strategic clinical and regulatory insight.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Southwood Research company profile →
Acsel Health
HQ: United States
Website
- Description: Provider of consulting services for the life sciences industry, ensuring patient access to life-saving medicines and helping life-changing innovations and health technologies reach their full potential through critical stages from early development to market maturity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acsel Health company profile →
3P Biopharmaceuticals
HQ: Spain
Website
- Description: Provider of biologics and cell therapy development and manufacturing services. Offers comprehensive CDMO support, including process and analytical development, preclinical and clinical supply, and commercial production. Produces proteins via mammalian (CHO, NS0, BHK-21, HEK293, Hybridoma) and microbial (E. coli, P. pastoris, S. cerevisiae, H. pylori, S. noursei) systems, and provides cell therapy technology transfer, process development, cell culture, and GMP certification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3P Biopharmaceuticals company profile →
Zenith Technologies
HQ: Ireland
Website
- Description: Provider of global full lifecycle automation, manufacturing, and operational support solutions for the life science industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zenith Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioBridges
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioBridges
2.2 - Growth funds investing in similar companies to BioBridges
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioBridges
4.2 - Public trading comparable groups for BioBridges
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →